Insulet (Nasdaq:PODD) announced today that it appointed Cristal Downing as its new chief corporate affairs officer, effective today. In the newly created role at the automated insulin delivery system developer, Downing will build and lead a corporate affairs function aimed at strengthening Insulet’s corporate reputation, advancing business priorities, catalyzing customer value and deepening engagement with […]
Personnel
Medtronic has a new head of investor relations, former head to join Diabetes spin-off MiniMed
![Medtronic named Ingrid Goldberg (right) as its new head of investor relations. Ryan Weispfenning (left) will leave to lead investor relations for MiniMed. [Images from LinkedIn]](https://www.drugdeliverybusiness.com/wp-content/uploads/2025/12/Medtronic-VP-Head-of-investor-relations-Ryan-Weispfenning-MiniMed-Ingrid-Goldberg-150x86.jpg)
Medtronic (NYSE: MDT) announced today that it named Ingrid Goldberg as its new VP and head of investor relations (IR). Goldberg’s appointment comes as Ryan Weispfenning, who previously held that role, elected to join the company’s Diabetes business and lead the IR function for the unit as it continues to work toward a separation from […]
Tidepool announces new permanent CEO appointment
Tidepool announced today that it appointed Brandon Arbiter as its CEO, following a six-month stint as the company’s interim CEO. Arbiter served as acting CEO since April 2025 after founder and CEO Howard Look stepped down to focus on his health. He previously held the post of VP of business development and strategic partnerships at […]
ViCentra adds Dexcom, Medtronic Diabetes veterans to leadership team
ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles. The Dutch insulin pump maker continues to expand its senior leadership as it looks to advance its Kaleido patch pump system. It appointed Karen Baxter, former VP and GM at Dexcom, to the position of SVP of sales for […]
Dexcom adds Stanford Medicine chair to its board of directors
Dexcom (Nasdaq:DXCM) announced today that it appointed Dr. Euan Ashley to its board of directors, effective Oct. 24, 2025. Ashley, a renowned researcher, entrepreneur and clinician, brings extensive leadership experience across healthcare research institutions and private organizations. He currently serves as chair of the Dept. of Medicine at Stanford Health. Research areas for Ashley span […]
Insulet adds JPMorgan veteran to its board of directors
Insulet (Nasdaq:PODD) announced today that it appointed Robert “Robbie” L. Huffines to its board of directors. Huffines, a former global chair of investment banking at JPMorgan Chase & Co., joins the automated insulin delivery technology maker’s board effective Oct. 31, 2025. He joins as an independent director and a member of the Insulet Audit Committee. […]
Modular Medical appoints new head of international operations as insulin patch pump advances
Modular Medical (Nasdaq:MODD) announced today that it appointed David Bosshard as its new head of international operations. Bosshard joins the company as it looks to advance its insulin delivery technology. San Diego-based Modular Medical develops pump technology designed for “almost-pumpers.” It targets adults with a user-friendly, affordable design. Modular Medical’s current pump, the MODD1, won […]
Insulet makes CFO change, appoints longtime J&J leader
Insulet (Nasdaq:PODD) announced today that it appointed Flavia Pease to succeed Ana Maria Chadwick as EVP and CFO. The transition goes into effect on Sept. 30, 2025, Chadwick intends to become a senior advisor to Insulet to ensure a smooth transition. “I want to personally thank Ana, who has provided steady and thoughtful leadership for […]
Insulet promotes from within to fill CTO role
Insulet (Nasdaq:PODD) announced today that it appointed Amit Guliani as its chief technology officer (CTO). Guliani’s appointment follows a nearly six-month tenure as acting CTO at the Acton, Massachusetts-based insulin pump maker. He took over in the interim role after Mark Field announced his departure in March. Previously, Guliani served as group VP, software engineering. […]
Insulet promotes Eric Benjamin to COO role, expands leadership team
Insulet (Nasdaq:PODD) announced today that it appointed Eric Benjamin to the role of chief operating officer (COO), effective immediately. The Acton, Massachusetts-based automated insulin delivery system maker also appointed Manoj Raghunandanan as chief growth officer. In his expanded role, Benjamin now leads Insulet’s end-to-end growth and innovation engine. He sets the strategy and guides execution […]
